Diamedica Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Diamedica Therapeutics (DMAC) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Diamedica Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Diamedica Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Diamedica Therapeutics by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $771k | 97k | 7.96 |
| 2025-09-30 | $635k | 92k | 6.87 |
| 2025-06-30 | $310k | 80k | 3.90 |
| 2025-03-31 | $50k | 13k | 3.79 |
| 2024-12-31 | $72k | 13k | 5.43 |
| 2024-09-30 | $56k | 13k | 4.19 |
| 2024-06-30 | $39k | 13k | 2.95 |
| 2024-03-31 | $37k | 13k | 2.77 |
| 2023-12-31 | $38k | 13k | 2.84 |
| 2023-09-30 | $34k | 13k | 2.58 |
| 2023-06-30 | $57k | 13k | 4.32 |
More positions owned by Charles Schwab Investment Management
View all positions for Charles Schwab Investment Management